How bacteria take shape
One possible route towards finding new antibiotics to counter pneumococci may be by developing a substance that effectively hinders the process of cell division. A research team led by Jan-Willem Veening of the Department of Molecular Genetics of the University of Groningen has recently identified a protein named StkP, which plays an important role in this process.
An intriguing question is how oval bacteria, such as the human pathogen Streptococcus pneumoniae (pneumococcus), know when to divide in order to avoid producing round or elongated daughter cells.
The researchers used biochemical and microscopic technologies to prove that StkP migrates to the centre of the cell, where it regulates important proteins that are involved in cell division. If StkP is absent, the pneumococci lose their characteristic oval shape and become rod-shaped. These rod-shaped pneumococci are less virulent because the human immune system finds them easier to recognize. Since StkP is present in all pathogenic pneumococci and is an essential ingredient in their virulence, this protein would be an excellent candidate for the development of new antibiotics.
An article about this study has been published in PNAS.
Further information:
Dr J.W. Veening, Assistant Professor of Molecular Genetics at the Groningen Biomolecular Sciences and Biotechnology Institute and Centre for Synthetic Biology of the University of Groningen, j.w.veening@rug.nl , tel. 050-363 2408
| Last modified: | 31 January 2017 11.13 p.m. |
More news
-
12 August 2019
Cold winters not caused by Arctic climate change
Recent studies into the relationship between decreases in sea ice in the Arctic and ice-cold winters in the mid-latitudes, like the Polar Vortex cold waves in North America, seem to suggest that such a connection does indeed exist. However, the mechanisms...
-
05 August 2019
New Zealand’s biodiversity will take millions of years to recover
The arrival of humans in New Zealand, some 700 years ago, triggered a wave of extinction among native bird species. Calculations by scientists from the University of Groningen in the Netherlands and Massey University in New Zealand show that it would...
-
31 July 2019
Closing the door: breaking new ground related to a potential anticancer drug target
In order to sustain fast growth, cancer cells need to take up nutrients at a faster rate than healthy cells. The human glutamine transporter ASCT2 allows the amino acid glutamine to enter cells and is upregulated in many types of cancer cells, which...